UNLABELLED: The aim of this study was to determine whether respiratory syncytial virus (RSV) and other viral lower respiratory tract infections (LRTI) in prematurely born infants were associated with similar effects on healthcare utilisation and related cost of care in the second compared to the first year after birth. Thirteen infants who had RSV LRTIs (RSV), 21 who had other viral LRTIs (other viral) and 25 had no viral LRTIs (no LRTI) were prospectively followed. Nasopharyngeal aspirates were collected whenever an infant had an LRTI regardless of whether it was in the hospital or in the community. Healthcare utilisation and the health-related cost of care were determined. Only the RSV group compared to the no LRTI group had higher overall respiratory costs in both year 1 (mean, £3,917 versus £24; p < 0.041) and year 2 (mean, £1,164 versus £61; p = 0.012). Only the RSV group required respiratory admissions; the RSV admission rate in year 2 was 3.4 % (number needed to treat 59). CONCLUSION: RSV LRTIs are associated with increased healthcare utilisation and cost of care in the first and second year; nevertheless, if prophylaxis is to be cost-effective in the second year, a high risk group needs to be identified.
UNLABELLED: The aim of this study was to determine whether respiratory syncytial virus (RSV) and other viral lower respiratory tract infections (LRTI) in prematurely born infants were associated with similar effects on healthcare utilisation and related cost of care in the second compared to the first year after birth. Thirteen infants who had RSV LRTIs (RSV), 21 who had other viral LRTIs (other viral) and 25 had no viral LRTIs (no LRTI) were prospectively followed. Nasopharyngeal aspirates were collected whenever an infant had an LRTI regardless of whether it was in the hospital or in the community. Healthcare utilisation and the health-related cost of care were determined. Only the RSV group compared to the no LRTI group had higher overall respiratory costs in both year 1 (mean, £3,917 versus £24; p < 0.041) and year 2 (mean, £1,164 versus £61; p = 0.012). Only the RSV group required respiratory admissions; the RSV admission rate in year 2 was 3.4 % (number needed to treat 59). CONCLUSION: RSV LRTIs are associated with increased healthcare utilisation and cost of care in the first and second year; nevertheless, if prophylaxis is to be cost-effective in the second year, a high risk group needs to be identified.
Authors: R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez Journal: Lancet Date: 1999-08-14 Impact factor: 79.321
Authors: A Greenough; J Alexander; P Boit; J Boorman; S Burgess; A Burke; P A Chetcuti; I Cliff; W Lenney; T Lytle; C Morgan; C Raiman; N J Shaw; K P Sylvester; J Turner Journal: Thorax Date: 2009-02-12 Impact factor: 9.139
Authors: Simon B Drysdale; Mireia Alcazar-Paris; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Simon Broughton; Gerrard F Rafferty; Janet L Peacock; Sebastian L Johnston; Anne Greenough Journal: Eur Respir J Date: 2013-04-05 Impact factor: 16.671
Authors: Simon B Drysdale; Theresa Wilson; Mireia Alcazar; Simon Broughton; Mark Zuckerman; Melvyn Smith; Gerrard F Rafferty; S L Johnston; Anne Greenough Journal: Thorax Date: 2011-03-28 Impact factor: 9.139
Authors: Maria Arroyo; Kyle P Salka; Geovanny F Perez; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Gustavo Nino Journal: J Investig Med Date: 2019-12-05 Impact factor: 2.895
Authors: Arij Faksh; Rodney D Britt; Elizabeth R Vogel; Michael A Thompson; Hitesh C Pandya; Richard J Martin; Christina M Pabelick; Y S Prakash Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-11-20 Impact factor: 5.464
Authors: Ioannis N Mammas; Simon B Drysdale; Barbara Rath; Maria Theodoridou; Georgia Papaioannou; Alexia Papatheodoropoulou; Eirini Koutsounaki; Chryssie Koutsaftiki; Eleftheria Kozanidou; Vassilis Achtsidis; Paraskevi Korovessi; George P Chrousos; Demetrios A Spandidos Journal: Int J Mol Med Date: 2020-06-15 Impact factor: 4.101
Authors: Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Iliana Christaki; Chryssie Koutsaftiki; Maria Koutsaki; Dimitra M Portaliou; Georgia Kostagianni; Paraskevi Panagopoulou; George Sourvinos; Demetrios A Spandidos Journal: Exp Ther Med Date: 2015-11-24 Impact factor: 2.447
Authors: Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany Journal: Infect Dis Ther Date: 2016-09-14
Authors: Steven M Brunwasser; Brittney M Snyder; Amanda J Driscoll; Deshayne B Fell; David A Savitz; Daniel R Feikin; Becky Skidmore; Niranjan Bhat; Louis J Bont; William D Dupont; Pingsheng Wu; Tebeb Gebretsadik; Patrick G Holt; Heather J Zar; Justin R Ortiz; Tina V Hartert Journal: Lancet Respir Med Date: 2020-08 Impact factor: 30.700